Post-COVID Thrombotic Risk Composite (D-dimer + Clinical) Calculator

Clinical calculation support · Verify results before clinical use

Clinical risk factor assessment

Select each clinical factor and provide D-dimer information to calculate the IMPROVE-DD point total.

—Score

Age > 60 years

Select the finding that applies to the patient.

+1 point

Previous VTE (DVT/PE)

Select the finding that applies to the patient.

+3 points

Known thrombophilia

Select the finding that applies to the patient.

+2 points

Lower-limb paralysis or paresis

Select the finding that applies to the patient.

+2 points

Active cancer

Select the finding that applies to the patient.

+2 points

Immobilization ≥ 7 days

Select the finding that applies to the patient.

+1 point

ICU/CCU stay

Select the finding that applies to the patient.

+1 point

D-dimer

A D-dimer ≥2 times the laboratory upper limit of normal (ULN) contributes 2 points.

0 or +2 points

Use the same units as the ULN.

The ULN must be greater than zero.

If you do not enter both numeric values, choose the known status below. Do not select a status if the result is unknown.

About IMPROVE-DD

IMPROVE-DD adds D-dimer elevation to clinical risk factors from the IMPROVE VTE model. The point weights displayed here are the factors and weights implemented in the supplied calculator.

Scoring criteria

FactorPoints
Age > 60 years1
Previous VTE (DVT/PE)3
Known thrombophilia2
Lower-limb paralysis or paresis2
Active cancer2
Immobilization ≥ 7 days1
ICU/CCU stay1
D-dimer ≥2× ULN2

Important interpretation limits

  • In the original IMPROVE-DD validation, a score ≥2 identified heightened VTE risk in hospitalized medically ill patients receiving thromboprophylaxis; this is not a validated standalone post-discharge treatment threshold for COVID-19.
  • MICHELLE trial eligibility used an IMPROVE VTE score ≥4, or a score of 2–3 with D-dimer >500 ng/mL; this is not identical to applying the IMPROVE-DD score bands above.
  • Evaluate clinical probability and investigate suspected DVT/PE using an appropriate diagnostic pathway; this calculator does not diagnose or exclude VTE.

References

Gibson CM, et al.IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Prediction of VTE Risk. TH Open. 2017;1:e56–e65. DOI / article
Ramacciotti E, et al.Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE). Lancet. 2022;399:50–59. DOI / article
American Society of Hematology (ASH).Living guidelines on anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary. Blood Advances. 2025;9:1247–1260. DOI / guideline
Clinical disclaimer: For clinician education and decision support only. This calculator is not a substitute for individualized clinical assessment or current local protocols. Do not start, stop, or extend anticoagulation based on this score alone. Consider bleeding risk, contraindications, renal function, patient preferences, and the clinical indication.